- Have any questions?
- 862-258-5500
- tdsteele@outlook.com
Nonclinical Safety Solutions provides expert toxicology consulting to support informed decision-making across all stages of drug development. Services are designed to identify, interpret, and manage safety risks while aligning nonclinical strategies with regulatory expectations. From early discovery guidance through IND-enabling programs and global submissions, NCSS delivers clear, science-driven insight to help advance therapeutic candidates with confidence.
Precision toxicology guidance to design, evaluate, and strengthen nonclinical safety programs from early development through clinical entry, grounded in scientific interpretation and regulatory alignment.
Independent scientific diligence to identify safety liabilities, evaluate impurity risk, and inform confident, data-driven development and investment decisions.
Strategic study planning and expert scientific oversight to ensure nonclinical programs are well-designed, appropriately scoped, and fully aligned with regulatory expectations.
Proactive regulatory insight to identify risks early, address critical data gaps, and build a defensible nonclinical strategy that supports efficient agency interactions.
Clear, cohesive, regulator-ready nonclinical narratives developed with direct insight into how FDA and global health authorities evaluate safety data.
Integrated interpretation of pharmacology, ADME, and PK/TK data to support exposure-based safety justifications, starting-dose rationale, and clinical translation.
Tailored nonclinical safety strategies addressing the unique challenges of oncology programs, biologics, imaging agents, and other complex therapeutic modalities where standard approaches may not apply.